2021.08.18 – Clinical Assessment and Management of Spasticity following Brain Injury (Recorded Webinar)
A David Strauss Memorial Clinical Lecture webinar featuring Cindy B. Ivanhoe, M.D.
After completing the checkout process, you will receive an email with further instructions and a file that includes information about receiving your ACBIS CEU.
Aired live August 18, 2021. Includes 1 ACBIS CEU.
In this David Strauss Memorial Clinical Lecture, Cindy B. Ivanhoe, M.D., discusses treatment goals and treatment options for individuals with spasticity.
- Identify goals of treating spasticity.
- Discuss pluses and minuses of treatment options.
- Understand the role of botulinum toxins in spasticity treatment.
- Discuss when to refer patients with brain injury for intrathecal baclofen therapy.
Dr. Ivanhoe is board certified in Physical Medicine and Rehabilitation and in Brain Injury Medicine. Dr. Ivanhoe did her clinical fellowship in Brain Injury and Stroke Rehabilitation through a government-funded grant to Baylor College of Medicine, centered at what was then the Institute for Rehabilitation and Research (TIRR) in the Texas Medical Center (now TIRR Memorial Hermann). Dr. Ivanhoe was co-director and then director of that Brain Injury and Stroke Program. Dr. Ivanhoe was a professor in the Baylor College of Medicine Department of Physical Medicine and Rehabilitation until her resignation, the summer of 2019. She is a clinical professor in the Department of Physical Medicine and Rehabilitation McGovern School of Medicine v. University of Texas Health Science Center at Houston. She is an admitting physician to the Brain Injury and Stroke Program at TIRR Memorial Hermann. Dr. Ivanhoe founded and served as Chief Medical Officer of a residential post-acute brain injury program until 2017; a program and philosophy of care conceptualized in her kitchen. She has served as faculty in courses across the US and abroad, and is most known for expertise in the treatment of spasticity and its role in functional recovery, medical complications of brain injury; at times, as an advocate for healthcare access. Her clinical experience has spanned the entire spectrum of brain injury from developmental disabilities, neurosurgical ICUs, and acute rehabilitation to long-term follow-up in the community. Her nonprofit, IF (Ivanhoe Foundation) supports endeavors that serve to improve the lives of those with brain injuries and other disabilities in the community. Dr. Ivanhoe is most known for pioneering the clinical use of interventions for spasticity including Intrathecal Baclofen therapy for which she was an investigator on the studies that led to its FDA approval, the use of botulinum toxins, and for teaching. She is published in articles and textbooks. Dr. Ivanhoe has served on the board of directors of the International Neurotoxin Association and their educational committees, as well as the board of Mentis Neuro Health until 2017. Dr. Ivanhoe is a member of speakers’ bureaus and/or advisory boards of companies involved in the treatment of spasticity and other aspects of the Upper Motor Neuron Syndrome. She is recognized by US News and World Report Best Doctors and Best Doctors in Texas and has received awards from the Brain Injury Association of Texas; American Congress of Rehabilitation Medicine; Baylor College of Medicine for her contributions to advocacy, teaching, and education; the service award from the CNS Council of the American Academy of Physical Medicine and Rehabilitation and the Distinguished Clinician Award by the American Academy of Physical Medicine and Rehabilitation. She was awarded the Humanitarian Award by the Brain Injury Alliance of Texas and has received the Professional Contribution and Lifetime Achievement Awards from the Brain Injury Association of Texas.